Literature DB >> 22365245

Idiopathic pulmonary fibrosis: phenotypes and comorbidities.

Charlene D Fell1.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive fatal disease of the lung with an unknown etiology and limited treatment options. Three distinct phenotypes of IPF have been proposed: combined pulmonary fibrosis and emphysema, disproportionate pulmonary hypertension in IPF, and rapidly progressive IPF. Although treatment options for IPF are limited, much can be done to identify and alleviate symptoms from comorbidities, potentially improving the overall quality of life and well-being of these patients. This article describes emerging evidence to support the hypothesis that there is more than one phenotype for IPF and describes the common comorbidities seen in this disease. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22365245     DOI: 10.1016/j.ccm.2011.12.005

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  11 in total

1.  Switching-Off Adora2b in Vascular Smooth Muscle Cells Halts the Development of Pulmonary Hypertension.

Authors:  Tinne C J Mertens; Ankit Hanmandlu; Ly Tu; Carole Phan; Scott D Collum; Ning-Yuan Chen; Tingting Weng; Jonathan Davies; Chen Liu; Holger K Eltzschig; Soma S K Jyothula; Keshava Rajagopal; Yang Xia; Ashrith Guha; Brian A Bruckner; Michael R Blackburn; Christophe Guignabert; Harry Karmouty-Quintana
Journal:  Front Physiol       Date:  2018-06-01       Impact factor: 4.566

2.  Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada.

Authors:  Jean-Eric Tarride; Robert B Hopkins; Natasha Burke; Jason R Guertin; Daria O'Reilly; Charlene D Fell; Genevieve Dion; Martin Kolb
Journal:  Clinicoecon Outcomes Res       Date:  2018-02-22

3.  Characteristics of lung cancer in idiopathic pulmonary fibrosis with single lung transplant versus non-transplanted patients: a retrospective observational study.

Authors:  Evgeni Gershman; Alona Zer; Barak Pertzov; Osnat Shtraichman; Dorit Shitenberg; Moshe Heching; Dror Rosengarten; Mordechai Kramer
Journal:  BMJ Open Respir Res       Date:  2020-06

Review 4.  Idiopathic Pulmonary Fibrosis: Epidemiology, Natural History, Phenotypes.

Authors:  Jaume Sauleda; Belén Núñez; Ernest Sala; Joan B Soriano
Journal:  Med Sci (Basel)       Date:  2018-11-29

5.  Risk factors for the development of idiopathic pulmonary fibrosis: A review.

Authors:  Tanzira Zaman; Joyce S Lee
Journal:  Curr Pulmonol Rep       Date:  2018-10-16

Review 6.  Hepatic fibrosis and the microenvironment: fertile soil for hepatocellular carcinoma development.

Authors:  Michael C Wallace; Scott L Friedman
Journal:  Gene Expr       Date:  2014

Review 7.  Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions.

Authors:  Anna Stainer; Paola Faverio; Sara Busnelli; Martina Catalano; Matteo Della Zoppa; Almerico Marruchella; Alberto Pesci; Fabrizio Luppi
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

Review 8.  Update on diagnosis and treatment of idiopathic pulmonary fibrosis.

Authors:  José Baddini-Martinez; Bruno Guedes Baldi; Cláudia Henrique da Costa; Sérgio Jezler; Mariana Silva Lima; Rogério Rufino
Journal:  J Bras Pneumol       Date:  2015 Sep-Oct       Impact factor: 2.624

Review 9.  Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives.

Authors:  Michael Kreuter; Francesco Bonella; Marlies Wijsenbeek; Toby M Maher; Paolo Spagnolo
Journal:  Biomed Res Int       Date:  2015-12-08       Impact factor: 3.411

10.  Development of a Consensus Statement for the Definition, Diagnosis, and Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis Using the Delphi Technique.

Authors:  Toby M Maher; Moira K B Whyte; Rachel K Hoyles; Helen Parfrey; Yuuki Ochiai; Nicky Mathieson; Alice Turnbull; Nicola Williamson; Bryan M Bennett
Journal:  Adv Ther       Date:  2015-10-23       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.